Skip to main content
Clinical Trials/CTRI/2022/03/041072
CTRI/2022/03/041072RecruitingPhase 2

Randomised double blind placebo controlled trial to evaluate the effects of Vanadium metallicum 6CH on blood haemoglobin level in reproductive age group of anaemic women

The Calcutta Homoeopathic Medical College and Hospital0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1. Anemic patients with hemoglobin level between 7 and 10 gm/dl
  • 2. Patients not undergoing any therapy
  • 3. Females of reproductive age group of 18-49 years
  • 4. Patients taking iron supplement will be advised to stop the supplement for 14 days, followed by re-assessment of blood haemoglobin in the next enrollment
  • 5. Providing with written informed consent voluntarily

Exclusion Criteria

  • 1. Patients with hemoglobin less than 7 gm/dL (severe anemia)
  • 2. Vulnerable population ââ?¬â?? unconscious, too sick for consultation, differently abled, terminally or critically ill patients
  • 3. Pregnant and puerperal women, lactating mothers
  • 4. Diagnosed cases of systemic diseases, unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life or any organ failure
  • 5. Self-reported immune-compromised state
  • 6. Substance abuse and/or dependence
  • 7. Undergoing homoeopathic treatment for any other chronic disease within last 6 months

Investigators

Sponsor
The Calcutta Homoeopathic Medical College and Hospital

Similar Trials